Pancreatic α-cell function in diabetic hemochromatotic subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 49, Issue 3, 1979, Pages 412-416

  Nelson, Roger L ^a,b   Baldus, William P ^a,b   Rubenstein, Arthur H ^b   Go, Vay L W ^a,b   Service, F John ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; GLUCAGON; INSULIN;

ARGININE INFUSION; CONGENITAL DISORDER; DIABETES MELLITUS; ENDOCRINE SYSTEM; HEMOCHROMATOSIS; HUMAN CELL; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NORMAL HUMAN; NORMAL VALUE; PANCREAS; PANCREAS ISLET ALPHA CELL; PANCREAS RESECTION; THEORETICAL STUDY;

ADULT; AGED; ARGININE; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS; GLUCAGON; HEMOCHROMATOSIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MIDDLE AGED; PANCREATECTOMY;

EID: 0018564801     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-49-3-412     Document Type: Article

References (38)

1. Stocks, A. E., and L. W. Powell, Carbohydrate intolerance in idiopathic haemochromatosis and cirrhosis of the liver, Q J Med 42: 733, 1973.
2. Dymock, I. W., J. Cassar, D. A. Pyke, W. G. Oakley, and R. Williams, Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis, Am J Med 52: 203, 1972.
3. Bomford, A., and R. Williams, Long term results of venesection therapy in idiopathic haemochromatosis, Q J Med 45: 611, 1976.
4. Walsh, C. H., J. M. Malins, and S. R. Bloom, Diabetes mellitus in idiopathic haemochromatosis, Br Med J 2: 1267, 1978.
5. Balcerzak, S. P., D. H. Mintz, and M. P. Westerman, Diabetes mellitus and idiopathic hemochromatosis, Am J Med Sci 255: 53, 1968.
6. Saddi, R., and J. Feingold, Idiopathic haemochromatosis and diabetes mellitus, Clin Genet 5: 242, 1974.
7. MacDonald, R. A., Hemochromatosis and Hemosiderosis, Charles C Thomas, Springfield, 1964, p. 232.
8. Vachon, A., J. Gauthier, R. Tete, Bizolon, and P. Kressmann, Le dosage de l'insuline plasmatique dans l'hemochromatose primitive, Rev Lyon Med 19: 531, 1970.
9. Muller, W. A., G. R. Faloona, E. Aguilar-Parada, and R. H. Unger, Abnormal alpha-cell function in diabetes: response to carbohydrate and protein ingestion, N Engl J Med 283: 109, 1970.
10. Sherwin, R., P. Joshi, R. Hendler, P. Felig, and H. O. Conn, Hyperglucagonemia in Laennec's cirrhosis: the role of portal-systemic shunting, N EnglJ Med 290: 239, 1974.
11. Donowitz, M., R. Hendler, H. M. Spiro, H. J. Binder, and P. Felig, Glucagon secretion in acute and chronic pancreatitis, Ann Intern Med 83: 778, 1975.
12. Ohneda, A., Y. Kai, S. Ishii, K. Matsuda, K. Horigome, Y. Maruhama, T. Takebe, and S. Yamagata, Insulin and glucagon response in patients with chronic pancreatitis, Tohoku J Exp Med 120: 287, 1976.
13. Lippe, B. M., M. A. Sperling, and R. R. Dooley, Pancreatic alpha and beta cell functions in cystic fibrosis, J Pediatr 90: 751, 1977.
14. Bergmeyer, H. U., and E. Bernt, Determination with glucose oxidase and peroxidase, In Bergmeyer, H. U. (ed.), Methods of Enzymatic Analysis, vol. 3, Academic Press, New York, 1974, p. 1205.
15. Service, F. J., C. M. Veneziale, R. A. Nelson, R. D. Ellefson, and V. L. W. Go, Combined deficiency of glucose-6-phosphatase and fructose- l, 6-diphosphatase: studies of glucagon secretion and fuel utilization, Am JMed 64: 696, 1978.
16. Starr, J. I., and A. H. Rubenstein, Insulin, proinsulin, and C-peptide, In Jaffe, B. M., and H. R. Behrman (eds.), Methods of Hormone Radioimmunoassay, Academic Press, New York, 1974, p. 289.
17. Unger, R. H., A. M. Eisentraut, M. S. McCall, and L. L. Madison, Glucagon antibodies and an immunoassay for glucagon, J Clin Invest 40: 1280, 1961.
18. Assan, R., and A. Tiengo, Comparaison des secretions de glucagon dans les diabetes sucres avec ou sans pancreatopathie organique acquise, Pathol Biol (Paris) 21: 17, 1973.
19. Passa, P., A. S. Luyckx, J. L. Carpentier, P. J. Lefebvre, and J. Canivet, Glucagon secretion in diabetic patients with idiopathic haemochromatosis, Diabetologia 13: 509, 1977.
20. Gonvers, J.-J., L. Henchoz, J.-R. Hofstetter, and W.-A. Muller, Etude de la secretion de glucagon chez des patients atteints d'hemochromatose, Schweiz Med Wochenschr 107: 1841, 1977.
21. Sheldon, J. H., Haemochromatosis, Oxford University Press, London, 1935.
22. Bell, E. T., The relation of portal cirrhosis to hemochromatosis and to diabetes mellitus, Diabetes 4: 435, 1955.
23. McGavran, M. H., and W. S. Hartroft, The predilection of pancreatic beta cells for pigment deposition in hemochromatosis and hemosiderosis, Am J Pathol 32: 631, 1956 (Abstract).
24. Valverde, I., and M. L. Villanueva, Heterogeneity of plasma immunoreactive glucagon, Metabolism 25: 1393, 1976.
25. Vranic, M., S. Pek, and R. Kawamori, Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs, Diabetes 23: 905, 1974.
26. Werner, P. L., and J. P. Palmer, Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man, Diabetes 27: 1005, 1978.
27. Wider, M. D., T. Matsuyama, J. C. Dunbar, and P. P. Foa, Elevated gut glucagon-like immunoreactive material in human and experimental diabetes and its suppression by somatostatin, Metabolism 25: 1487, 1976.
28. Villanueva, M. L., J. A. Hedo, and J. Marco, Plasma glucagon immunoreactivity in a totally pancreatectomized patient, Diabetologia 12: 613, 1976.
29. Marco, J., J. Diego, M. L. Villanueva, M. Diaz-Fierros, I. Valverde, and J. M. Segovia, Elevated plasma glucagon levels in cirrhosis of the liver, N EnglJ Med 289: 1107, 1973.
30. Sherwin, R. S., M. Fisher, J. Bessoff, N. Snyder, R. Hendler, H. O. Conn, and P. Felig, Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon, Gastroenterology 74: 1224, 1978.
31. Bastl, C, F. O. Finkelstein, R. Sherwin, R. Hendler, P. Felig, and J. P. Hayslett, Renal extraction of glucagon in rats with normal and reduced renal function, Am J Physiol 233: F67, 1977.
32. McDonald, T. J., A. Aronoff, J. Radziuk, and J. Dupre, Hypersecretion of glucagon in liver disease with portal-systemic vascular shunt, Clin Res 23: 637A, 1975 (Abstract).
33. Wise, J. K., R. Hendler, and P. Felig, Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects, N EnglJ Med 288: 487, 1973.
34. Gossain, V. V., M. L. Matute, and R. K. Kalkhoff, Relative influence of obesity and diabetes on plasma alpha-cell glucagon, J Clin Endocrinol Metab 38: 238, 1974.
35. Berger, D., R. C. Crowther, J. C. Floyd Jr., S. Pek, and S. S. Fajans, Effect of age on fasting plasma levels of pancreatic hormones in man, J Clin Endocrinol Metab 47: 1183, 1978.
36. Gerich, J. E., E. Tsalikian, M. Lorenzi, V. Schneider, N. V. Bohannon, G. Gustafson, and J. H. Karam, Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin, J Clin Endocrinol Metab 41: 1178, 1975.
37. Tsalikian, E., T. W. Dunphy, N. V. Bohannon, M. Lorenzi, J. E. Gerich, P. H. Forsham, J. P. Kane, and J. H. Karam, The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal, Diabetes 26: 314, 1977.
38. Walsh, C. H., A. D. Wright, J. W. Williams, and G. Holder, A study of pituitary function in patients with idiopathic hemochromatosis, J Clin Endocrinol Metab 43: 866, 1976.